Downregulation of AP-1 repressor JDP2 is associated with tumor metastasis and poor prognosis in patients with pancreatic carcinoma

International Journal of Biological Markers

Volumn 25, Issue 3, 2010, Pages 136-140

  Xu, Yuanhong ^a   Xu, Feng ^a   Li, Qingchang ^a   Fan, Jianpeng ^a   Liu, Zhe ^a   Guo, Kejian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Jun dimerization protein 2; Pancreatic carcinoma; Patient prognosis; Tumor metastasis

Indexed keywords

SPHINGOLIPID ACTIVATOR PROTEIN 1; TRANSCRIPTION FACTOR JUN DIMERIZATION PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; DISTANT METASTASIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PANCREAS CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; WESTERN BLOTTING;

ADENOCARCINOMA; AGED; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROGNOSIS; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR AP-1;

EID: 78650805749     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aronheim A, Zandi E, Hennemann H, Elledge SJ Karin M. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol 1997; 17: 3094-102.
2. Jin C, Ugai H, Song J, et al. Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2. FEBS Lett 2001; 489: 34-41.
3. Weidenfeld-Baranboim K, Hasin T, Darlyuk I, et al. The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3. Nucleic Acids Res 2009; 37: 2194-203.
4. Kimura M. IRF2-binding protein-1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2-dependent transcription. FEBS Lett 2008; 582: 2833-7.
5. Matthews CP, Colburn NH, Young MR. AP-1 a target for cancer prevention. Curr Cancer Drug Targets 2007; 7: 317-24.
6. Lerdrup M, Holmberg C, Dietrich N, et al. Depletion of the AP-1 repressor JDP2 induces cell death similar to apoptosis. Biochim Biophys Acta 2005; 1745: 29-37.
7. Heinrich R, Livne E, Ben-Izhak O, Aronheim A.The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. J Biol Chem 2004; 279: 5708-15.
8. Yachida S, Iacobuzio-Donahue CA. The pathology and genetics of metastatic pancreatic cancer. Arch Pathol Lab Med 2009; 133: 413-22.
9. Seven Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut 2007; 56: 1134-52.
10. Schneider G, Hamacher R, Eser S, Friess H, Schmid RM, Saur D. Molecular biology of pancreatic cancer - new aspects and targets. Anticancer Res 2008; 28: 1541-50.
11. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 2005; 95: 918-31.
12. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859-68.
13. Ju KD, Yu JH, Kim H, Kim KH. Role of mitogen-activated protein kinases, NF-kappaB, and AP-1 on cerulein-induced IL-8 expression in pancreatic acinar cells. Ann N Y Acad Sci 2006; 1090: 368-74.